Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality and artificial intelligence, MindMaze has enhanced recovery potential for patients with neurological diseases.

Combining FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI and cloud technologies, MindMaze aims to create the universal platform for brain health. The company also operates MindMaze Labs, an R&D division dedicated to bringing neuroscience expertise to everyday life and advancing human-machine interfaces.

MindMaze's portfolio includes digital neurotherapeutics for brain repair, teleneurorehabilitation, and motion-sensing technology that delivers innovative solutions for neurological disease treatment and rehabilitation across clinical and patient needs.

MindMaze strives to pioneer digital therapies and assessments powered by medical-grade software, interactive content, and proprietary peripherals to restore motor, cognitive, and cardiovascular functions for patients with neural injuries, degeneration, and aging conditions. Their goal is to transform neurorehabilitation with scalable, adaptable digital platforms and immersive therapeutic experiences that profoundly impact patients and caregivers worldwide.

As a company, MindMaze also seeks to expand its impact beyond healthcare by fostering innovation across different industries through MindMaze Labs and continuing to grow its clinical development pipeline and global commercial presence.